A
Atonarp
A pioneer in developing technology for real-time chemical composition analysis
About Atonarp
Atonarp is a technology startup that operates at the intersection of digital technology and molecular insights. It primarily serves clients in the life science research, semiconductor, and industrial process control sectors. The company's core offering is its digital molecular profiling technology, which is used to improve efficiency and reduce waste in various manufacturing processes, including those in the semiconductor, pharmaceutical, and life sciences industries.
Atonarp's technology is based on mass spectrometry and multi-laser optical spectrometry platforms. Mass spectrometry is a technique used to identify the amount and type of chemicals present in a sample by measuring the mass-to-charge ratio and abundance of gas-phase ions. In simpler terms, it's a way of figuring out what something is made of and how much of each thing is present. Atonarp's platforms use this technology, along with advanced analytics, to provide real-time, quantitative, and actionable results.
In addition to industrial process control, Atonarp also offers in vitro diagnostic tests for the life science research sector. These tests are chemistry-free and quantitative, meaning they can provide precise measurements without the need for chemical reactions. This allows for real-time disease diagnosis and monitoring, which can lead to improved patient outcomes and satisfaction, all at a lower cost.
Atonarp's business model is likely based on selling its technology and services to its clients in the aforementioned sectors. By helping these clients improve their manufacturing processes and research capabilities, Atonarp can generate revenue while also contributing to advancements in these industries.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2010
- Headquarters
- Tokyo, Japan
- Employees
- 31
- Open positions
- None listed
- Dealroom signal
- 69.9/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Analytics, Drug Development, Remote Monitoring, Chemistry, Health Diagnostics, Tech for Biotech and Pharma, Semiconductor Engineering Tools, Semiconductor Engineering Equipment
- Technology
- Deep Tech
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | May 2021 | $50M | $200M | Furukawa Electric · Banner Industries · Japan Post Investment · Boscolo Intervest | — |
| SERIES COther financing | Aug 2019 | $33M | $132M | Post Investment Group · SBI Investment | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Atonarp is 1.8K monthly website visits, down 50% over the last three months. Atonarp's team declined 6.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Walden International
Celesta Capital
Series B and later9 investors entered at this stage
Nec
INCJ
Post Investment Group
SBI Investment
Furukawa Electric
Banner Industries
Japan Post Investment- BIBoscolo Intervest
ATI Korea
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Atonarp on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Atonarp’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







